Registration Number
SC070691
Registered Address
1 George Square Glasgow Scotland G2 1AL
Company Status
Active
Employee Count
634
Turnover
£142,727,000
EBITDA
£81,106,000
Website
catalent.comCompany Type
Private limited Company
Incorporated on
20 February 1980
Nature of Business (SIC)
21100 - Manufacture of basic pharmaceutical products
Industries
0
Region
West of Scotland£50,168,000
£327,039,000
Filed
01 Feb 2024
Period
01 Jul 2023 - 31 Dec 2023
Average Time to Pay
74 days
Payment Periods
Shortest
30 days
Longest
60 days
Max Contractual
60 days
Not Paid Within Terms
47%
Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
---|---|---|---|---|---|---|
01 Jul 2023 - 31 Dec 2023 | 01 Feb 2024 | 74 | 18% | 48% | 34% | 47% |
01 Jan 2023 - 30 Jun 2023 | 04 Aug 2023 | 61 | 26% | 44% | 30% | 46% |
01 Jul 2022 - 31 Dec 2022 | 30 Jan 2023 | 51 | 23% | 58% | 19% | 47% |
01 Jan 2022 - 30 Jun 2022 | 29 Jul 2022 | 47 | 32% | 4% | 64% | 40% |
01 Jul 2021 - 31 Dec 2021 | 31 Jan 2022 | 56 | 27% | 47% | 26% | 52% |
01 Jan 2021 - 30 Jun 2021 | 30 Jul 2021 | 68 | 13% | 47% | 40% | 65% |
01 Jul 2020 - 31 Dec 2020 | 25 Jan 2021 | 61 | 20% | 45% | 35% | 60% |
01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 72 | 19% | 33% | 48% | 67% |
01 Jul 2019 - 31 Dec 2019 | 24 Jan 2020 | 54 | 24% | 46% | 30% | 59% |
01 Jan 2019 - 30 Jun 2019 | 25 Jul 2019 | 58 | 25% | 47% | 28% | 57% |
01 Jul 2018 - 31 Dec 2018 | 14 Jan 2019 | 52 | 21% | 56% | 23% | 59% |
01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 | 51 | 19% | 55% | 26% | 75% |
01 Jul 2017 - 31 Dec 2017 | 31 Jan 2018 | 47 | 21% | 56% | 23% | 70% |
CATALENT U.K
SWINDON ZYDIS LIMITED is a leading pharmaceutical company based in Swindon, United Kingdom
They specialize in the development and manufacturing of innovative drug delivery technologies, with a focus on their proprietary Zydis technology
Their sustainability program is an integral part of the company's operations, with a commitment to reducing their environmental impact and promoting sustainable practices
They have implemented various initiatives such as energy-efficient manufacturing processes, waste reduction programs, and sustainable sourcing of raw materials
CATALENT U.K
SWINDON ZYDIS LIMITED offers a range of products and services to their clients, including formulation development, clinical manufacturing, and commercial scale production of oral solid dose and biologic products
Their flagship product, Zydis, is a fast-dissolving oral dosage form that provides enhanced patient compliance and convenience
The company is led by a team of experienced and dedicated individuals, including Mark Surber (President, Biologics & Specialty Delivery) and Simon Downing (Managing Director)
They are committed to driving innovation and growth within the pharmaceutical industry
For more information on CATALENT U.K
SWINDON ZYDIS LIMITED and their services, you can visit their website at www.catalent.com/uk/swindon-zydis or contact their registered office at 1 Alder Road, Blagrove, Swindon, SN5 8RU, United Kingdom
The average time taken for CATALENT U.K. SWINDON ZYDIS LIMITED to pay invoices has been increasing since the first recorded period in 2017, reaching a peak in 2023. The percentage of invoices paid within 30 days has also been decreasing over time, while the percentage of invoices paid between 31 and 60 days and later than 60 days has been increasing. Additionally, the percentage of invoices not paid within agreed terms has been fluctuating but has generally been decreasing since 2020.
The volatility of CATALENT U.K. SWINDON ZYDIS LIMITED's payment behavior can be seen in the fluctuation of the percentage of invoices not paid within agreed terms, which has shown significant changes over the years. However, the company has maintained a consistent average time to pay and percentage of invoices paid within 30 days.
From 2017 to 2023, CATALENT U.K. SWINDON ZYDIS LIMITED has seen an increase in their average time to pay invoices and a decrease in the percentage of invoices paid within 30 days. There was a notable improvement in the percentage of invoices not paid within agreed terms in 2021, but it has since fluctuated. The worst period for the company was in 2020, where the percentage of invoices paid later than 60 days was the highest.
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Payment terms including any standard contractual length of time for payment of invoices and the maximum contractual payment period, any changes to standard terms, whether suppliers have been notified or consulted on these changes.
Were there any changes to the standard payment terms in the reporting period?
No
Any other information about payment terms
n/a
Maximum contractual payment period agreed
60
Complaints or concerns on non-payment are initially received and dealt with by the company's Finance department. Where possible simple, straight forward issues, for example administrative errors, will be resolved without the need for further escalation. Disputes involving more complex issues such as non-performance, pricing discrepancies or breach of contractual terms will be referred to the company's Commercial or Operations teams to liaise with the supplier and resolve. If required, disputes will be escalated to the company's Leadership team and/or Legal department to negotiate and resolve the issues arising.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
✅
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
❌